Amidines are potent inhibitors of nitric oxide synthases: Preferential inhibition of the inducible isoform

被引:32
作者
Southan, GJ
Szabo, C
OConnor, MP
Salzman, AL
Thiemermann, C
机构
[1] CHILDRENS HOSP,MED CTR,DIV CRIT CARE,CINCINNATI,OH 45229
[2] UNIV LONDON ST BARTHOLOMEWS HOSP & MED COLL,WILLIAM HARVEY RES INST,LONDON EC1M 6BQ,ENGLAND
来源
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION | 1995年 / 291卷 / 03期
关键词
nitric oxide; NO; amidine; butyramidine; blood pressure; shock; inflammation; endothelium; endotoxin; isothiourea;
D O I
10.1016/0922-4106(95)90071-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We evaluated the ability of simple alkyl amidines to inhibit the activity of the inducible isoform of nitric oxide (NO) synthase in vitro. In immunostimulated J774 macrophages, 2-iminopiperidine (EC(50) = 10 mu M) and butyramidine (EC(50) = 60 mu M) were more potent than N-G-methyl-L-arginine (EC(50) = 70 mu M) in inhibiting nitrite formation. The five amidines tested for their ability to inhibit the conversion of L-arginine to L-citrulline by bovine endothelial cell homogenates (a source of the constitutive, endothelial NO synthase isoform) were less effective than N-G-nitro-L-arginine or N-G-methyl-L-arginine. The rank-order of the potencies of the amidines against the endothelial NO synthase was, in general, similar to the rank-order of the presser effects of these agents in anesthetized rats. Thus, certain amidines are potent inhibitors of NO synthase, and are more selective towards the inducible NO synthase than the commonly used L-arginine based NO synthase inhibitors.
引用
收藏
页码:311 / 318
页数:8
相关论文
共 43 条
[1]  
Babbedge, Bland-Ward, Hart, Moore, Inhibition of rat cerebellar nitric oxide synthase by 7-nitroindazole and related substituted indazoles, Br. J. Pharmacol., 110, (1993)
[2]  
Benyo, Kiss, Szabo, Csaki, Kovach, Importance of basal nitric oxide synthesis in the regulation of myocardial blood flow, Cardiovasc. Res., 25, (1991)
[3]  
Boughton-Smith, Evans, Whittle, Characterisation of nitric oxide synthase activity in the rat colonic mucosa and muscle after endotoxin and in a model of colitis, Agents Actions, 41, (1994)
[4]  
Corbett, Tilton, Chang, Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction, Diabetes, 41, (1992)
[5]  
Dinerman, Lowenstein, Snyder, Molecular mechanisms of nitric oxide production. Potential relevance to cardiovascular disease, Circ. Res., 73, (1993)
[6]  
Fastier, Smirk, Circulatory properties of iso-thioureas, guanidines, iso-ureas and amidines, J. Pharmacol., 89, (1947)
[7]  
Gardiner, Compton, Bennett, Palmer, Moncada, Control of regional blood flow by endothelium-derived nitric oxide, Hypertension, 15, (1990)
[8]  
Garvey, Oplinger, Tanoury, Sherman, Fowler, Marshall, Harmon, Paith, Furfine, Potent and selective inhibition of human nitric oxide synthases, J. Biol. Chem., 269, (1994)
[9]  
Gross, Stuehr, Aisaka, Jaffe, Levi, Griffith, Macrophage and endothelial cell nitric oxide synthesis: cell-type selective inhibition by N<sup>G</sup>-aminoarginine, N<sup>G</sup>-nitroarginine and N<sup>G</sup>-methylarginine, Biochem. Biophys. Res. Comm., 170, (1990)
[10]  
Gross, Jaffe, Levi, Kilbourn, Cytokine-activated endothelial cells express an isotype of nitric oxide synthase which is tetrahydrobiopterin-dependent calmodulin-independent and inhibited by arginine analogs with a rank-order of potency characteristic of activated macrophages, Biochemical and Biophysical Research Communications, 87, (1991)